genomics

2 articles
The Motley FoolThe Motley Fool··Rick Munarriz

Cathie Wood's Selective Week: ARK Invest Adds Only 3 Stocks Amid Market Volatility

ARK Invest bought just three stocks last week—Figma, Arcturus Therapeutics, and 10x Genomics—signaling selective conviction in growth equities amid broader market uncertainty.
FIGARCTTXGbiotechSaaS
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

SNP Genotyping Market Poised to Double to $19.5B by 2034

SNP genotyping market projected to grow from $8.08B (2026) to $19.48B (2034) at 11.7% annual rate, driven by personalized medicine adoption and genomic technology advances.
ILMNRHHBYTMOREGNMYGNpersonalized medicineprecision medicine